China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.20
+0.56 (6.48%)
At close: Mar 27, 2026

HKG:2877 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,1353,7784,5173,9513,224
Revenue Growth (YoY)
-17.01%-16.35%14.32%22.55%21.38%
Cost of Revenue
869.21946.291,1221,012813.21
Gross Profit
2,2662,8323,3942,9382,410
Selling, General & Admin
1,4451,8892,3082,0981,756
Research & Development
103.1100.52110.46117.45112.71
Operating Expenses
1,5841,9962,4242,2251,876
Operating Income
682.07835.99970.1713.58534.37
Interest Expense
-5.69-6.13-2.74-0.63-1.25
Interest & Investment Income
393.31189.35105.5199.1104.14
Currency Exchange Gain (Loss)
--55.446.61-8.52-2.9
Other Non Operating Income (Expenses)
199.57177.94163.17113.37102.23
EBT Excluding Unusual Items
1,2691,1421,243916.9736.58
Gain (Loss) on Sale of Assets
-4.01-2.390.13-16.47
Pretax Income
1,2691,1461,240917.03720.1
Income Tax Expense
319.32305.67270.74194.25163.43
Earnings From Continuing Operations
949.95840.05969.51722.77556.67
Net Income
949.95840.05969.51722.77556.67
Net Income to Common
949.95840.05969.51722.77556.67
Net Income Growth
13.08%-13.35%34.14%29.84%88.68%
Shares Outstanding (Basic)
754755755755755
Shares Outstanding (Diluted)
754755755755755
Shares Change (YoY)
-0.19%--0.03%-0.21%
EPS (Basic)
1.261.111.280.960.74
EPS (Diluted)
1.261.111.280.960.74
EPS Growth
13.30%-13.35%34.14%29.79%89.08%
Free Cash Flow
-823.02788.31980.21609.52
Free Cash Flow Per Share
-1.091.041.300.81
Dividend Per Share
-0.5400.4200.3200.390
Dividend Growth
-28.57%31.25%-17.95%21.88%
Gross Margin
72.28%74.95%75.15%74.38%74.77%
Operating Margin
21.75%22.13%21.48%18.06%16.58%
Profit Margin
30.30%22.23%21.47%18.30%17.27%
Free Cash Flow Margin
-21.78%17.45%24.81%18.91%
EBITDA
737.52891.441,019888.23705.11
EBITDA Margin
23.52%23.59%22.56%22.48%21.87%
D&A For EBITDA
55.4555.4549.02174.65170.75
EBIT
682.07835.99970.1713.58534.37
EBIT Margin
21.75%22.13%21.48%18.06%16.58%
Effective Tax Rate
25.16%26.68%21.83%21.18%22.70%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.